The Chinese ophthalmic medical equipment industry is facing both structural opportunities and challenges. Significant changes in the disease spectrum form a solid basis for market growth: on one hand, an aging population continues to increase the number of middle-aged and elderly patients with eye diseases—there are approximately 170 million cataract patients and 21.8 million glaucoma patients in China; on the other hand, myopia among adolescents is becoming more common and occurring at younger ages, with around 130 million adolescents affected. Additionally, the rising risk of retinal complications due to diabetes and other chronic diseases further drives ophthalmic care needs to shift from treating existing conditions to prevention, early detection, and long-term management.
Given the substantial disease burden, the ophthalmic equipment market has entered a period of rapid growth, driven by policy guidance and technological advancements. China’s “14th Five-Year Plan” for eye health and myopia prevention initiatives strongly support the development of screening networks and equipment deployment, while technological innovation serves as the core driver for industry upgrading. Diagnostic devices such as ophthalmic OCT and optical biometry instruments are evolving toward higher precision, faster operation, and more intelligent analysis capabilities. Moreover, the pace of domestic substitution has accelerated significantly, with local companies leveraging advanced core technologies and better cost-effectiveness to gain a competitive edge in specific areas like OCT and optical biometry.
Looking ahead, industry growth will focus more on “primary-level accessibility” and “value extension.” With the improvement of the hierarchical medical system and inclusive healthcare policies, portable, automated, and intelligent eye screening devices are expected to be deployed in community and school settings, facilitating large-scale early screening. At the same time, the integration of artificial intelligence and optical technologies is transforming devices from standalone diagnostic tools into comprehensive, full-cycle eye health solutions that include screening, diagnosis, and follow-up management. As a result, the industry ecosystem is shifting from product manufacturing to sustainable health service models.
The Chinese ophthalmic medical equipment industry is currently facing both structural opportunities and challenges. Profound shifts in the disease spectrum provide a solid foundation for market growth: on one hand, an aging population continues to expand the population of middle-aged and elderly patients with ophthalmic diseases—China has approximately 170 million cataract patients and 21.8 million glaucoma patients; on the other hand, myopia among adolescents is becoming increasingly prevalent and occurring at younger ages, with around 130 million adolescents affected in China. In addition, the rising risk of diabetic and other chronic disease-related retinal complications is further driving ophthalmic care demand to shift from disease treatment toward prevention, early detection, and long-term management.
Against this backdrop of a substantial disease burden, the ophthalmic equipment market has entered a period of rapid growth, propelled by policy guidance and technological breakthroughs. The national “14th Five-Year Plan” for eye health and myopia prevention initiatives strongly support the establishment of screening networks and equipment deployment, while technological innovation serves as the core engine for industry upgrading. Diagnostic devices, such as ophthalmic OCT and optical biometry instruments, are evolving toward higher precision, faster operation, and more intelligent analytical capabilities. Meanwhile, the pace of domestic substitution has accelerated significantly, with local companies leveraging advances in core technologies and superior cost-effectiveness to establish strong competitiveness in segments such as OCT and optical biometry.
Looking ahead, industry growth will increasingly focus on “primary-level accessibility” and “value extension.” With the improvement of the hierarchical medical system and the promotion of inclusive healthcare policies, portable, automated, and intelligent eye screening devices are expected to penetrate community and school settings, enabling large-scale early screening. At the same time, the deep integration of artificial intelligence and optical technologies is transforming devices from single-purpose diagnostic tools into comprehensive, full-cycle eye health solutions that encompass screening, diagnosis, and follow-up management. The industry ecosystem is thus evolving from product manufacturing to sustainable health service models.
